4 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 4 |
Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy OCTA plus OCT guided 3+PRN regimen, OCT guided 3+PRN regimen, Anti-VEGF drug - Polypoidal Choroidal Vasculopathy | Phase 4 | Unknown | Xiaodong Sun | 102 | 2020-06-01 | 2020-05-08 |
| Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy Triamcinolone Acetonide, Ranibizumab - Wet Macular Degeneration | Phase 4 | Unknown | Aier School of Ophthalmology, Central South University | 120 | 2017-01-01 | 2018-11-30 |
| Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy ranibizumab - Exudative Age-related Macular Degeneration, Polypoidal Choroidal Vasculopathy | Phase 4 | Unknown | Pusan National University Hospital | 28 | 2016-11-22 | 2019-10-10 |
| The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) Conbercept - Polypoidal Choroidal Vasculopathy (PCV) | Phase 4 | Unknown | Chengdu Kanghong Biotech Co., Ltd. | 300 | 2015-10-01 | 2017-07-19 |
Choroid Diseases (4) · Choroidal Neovascularization (4) · Eye Diseases (4) · Metaplasia (4) · Neovascularization, Pathologic (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Uveal Diseases (4) · Macular Degeneration (1) · Retinal Degeneration (1) · Retinal Diseases (1)
Ranibizumab (2) · KH902 fusion protein (1) · Triamcinolone Acetonide (1)
Aier School of Ophthalmology, Central South University (1) · Chengdu Kanghong Biotech Co., Ltd. (1) · Pusan National University Hospital (1) · Xiaodong Sun (1)
China (3) · South Korea (1)
Ji Eun Lee, MD, PhD (1) · Shibo Tang (1) · Xiaodong Sun (1)